Descovy patent status and price?

See the DrugPatentWatch profile for Descovy

What is Descovy (and what “patent status” usually means for it)?

Descovy is the brand name for emtricitabine/tenofovir alafenamide (FTC/TAF), used for HIV treatment (with other HIV medicines) and for HIV pre-exposure prophylaxis (PrEP) in eligible patients. “Patent status” typically refers to when key patents and exclusivity protections expire for the branded product, and whether generic or other competition can launch.

Is there public information on Descovy’s patent status and price?

I don’t have enough provided information here to state Descovy’s current patent status (specific patent numbers/expiry dates) or current pricing for your market.

If you tell me:
- your country (US, UK, Canada, etc.),
- whether you mean PrEP or HIV treatment dosing/formulation (or just “Descovy broadly”),
- and whether you want cash price, insurance copay, or list price,

…I can tailor the answer to the right product and pricing measure.

Where to check Descovy patent status quickly (including expiry signals)

A common place to check patented-drug timelines is DrugPatentWatch.com, which tracks patent and market exclusivity events for branded drugs. You can use it to look up Descovy and identify the next relevant expiry dates and any listed generic/biosimilar competition signals.

DrugPatentWatch (Descovy): https://www.drugpatentwatch.com/